Glycan in Diseases and Therapeutics
The start of the 21th century denoted the beginning of present day prescription with glycan-based treatments at the bleeding edge. Be that as it may, glycan’s immediately became eclipsed as DNA-and protein-cantered medicines turned out to be promptly open. The on-going advancement of new instruments and systems to study and deliver basically characterized sugars has prodded re-established enthusiasm for the remedial uses of glycan. Fundamentals of glycobiology audit centres around progresses inside the previous decade that are taking glycan-based medications back to the bleeding edge of medication and the innovations that are driving these endeavors. These incorporate the utilization of glycan themselves as helpful particles just as designing protein and cell surface glycan to suit clinical applications to that of databases giving glycoenzyme information. Glycan therapeutics offer a rich and promising boondocks for improvements in the scholastic, biopharmaceutical, and medicinal fields.
Martin Dalziel and their associates at Oxford University found out about glycan’s with regards to pathogen attack, malignancy and autoimmunity, and inborn maladies. Biota, GlaxoSmithKline, Gilead and Roche are the organizations chiefly concentrating examination on glycan area of ailments and its remedial applications. The Company's definitive objective is to bring to showcase promising novel classes of helpful operators, utilitarian nourishments, and diagnostics dependent on the normally happening bioactive glycan’s.
- Congenital disorders of glycosylation (CDG)
- Cancer biomarkers
- Glycomedicine
- Cardiovascular diseases
- Cardiac arrest
- Transfusion medicine
- Cancer associated coagulopathies
Related Conference of Glycan in Diseases and Therapeutics
Glycan in Diseases and Therapeutics Conference Speakers
Recommended Sessions
- Agricultural and Food Chemistry
- Animal and Plant Biochemistry
- Biochemistry
- Bioinformatics
- Bioorganic and Biological Chemistry
- Cell Signalling
- Clinical Biochemistry
- DNA Punctuation
- Genomics and Proteomics
- Glycan in Diseases and Therapeutics
- Glycan in Drug Discoveries
- Glyco Immunology
- Glycobiology
- Glycobiology in Lipid Science
- Glycochemistry
- Glycoscience
- Nano Biochemistry
- Proteoglycan and Sialic acid
- Recent Advances in Glycobiology
- Structural Biochemistry
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)